Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

Inclusion Criteria

• •Adults ≥ 18 years old.
• •A T1D diagnosis for at least one year, as per their treating physician in agreement with the investigator's judgment (confirmatory C-peptide and antibodies will not be required).
• •HbA1c level of \< 11% within the last six months.
• •Current use of intensive insulin therapy, either multi-daily injection or closed-loop insulin pump therapy, with no plan to change during the study.
• •Current use of CGM, either real-time or intermittent.
• •Active avoidance of pregnancy during the trial, which includes effective contraception for any individuals of childbearing potential, who are sexually active.
• •Ability to consume an average of more than 50 g of carbohydrates per day.
• •Use of a compatible phone to allow for download of the CKM sensor application.